Gastrointestinal motility disorders affect how food and waste move through your digestive system, causing uncomfortable symptoms that can significantly impact your daily life. Understanding the available treatment options, from simple lifestyle changes to innovative therapies being tested in research settings, can help you work with your healthcare team to find the right approach for your condition.

Understanding Treatment Goals for Motility Disorders

When your digestive tract stops moving food and waste along as it should, the primary goals of treatment focus on relieving symptoms, restoring normal function where possible, and improving your quality of life. Treatment approaches vary widely depending on which part of your gastrointestinal tract—the pathway from your mouth to your rectum—is affected and how severe your symptoms are.^[1][2]

The choice of treatment depends on several factors, including the specific type of motility disorder you have, the stage of the disease, and your personal characteristics such as age, overall health, and other medical conditions you might have. What works well for one person may not be appropriate for another, which is why doctors carefully evaluate each patient’s unique situation before recommending a treatment plan.^[4]

In current medical practice, there are well-established standard treatments approved by medical societies and healthcare organizations. These include medications, dietary modifications, and in some cases, surgical procedures. At the same time, researchers continue to explore new therapies through clinical trials, testing innovative drugs and approaches that may offer hope for people who haven’t found relief with existing treatments.^[10][12]

The complexity of motility disorders means that treatment often involves multiple approaches working together. Because these conditions can affect the enteric nervous system—the network of nerves that controls your digestive tract—treatment may need to address both the physical movement of food and the nerve signals that coordinate this movement.^[8]

Standard Medical Treatment Options

The cornerstone of treating gastrointestinal motility disorders includes several well-established medications and therapies that have been used successfully for many years. The specific drugs prescribed depend on which part of your digestive system is affected and what symptoms you’re experiencing.

Medications for Different Motility Disorders

For conditions affecting the esophagus, such as achalasia, doctors may prescribe calcium-channel blockers like nifedipine or nitrates such as isosorbide. These medications work by relaxing the muscles in the lower esophagus, making it easier for food to pass into the stomach. When swallowing becomes difficult, botulinum toxin (commonly known as Botox) can be injected directly into the esophageal muscles to help them relax.^[9][11]

When the stomach empties too slowly—a condition called gastroparesis—prokinetic agents play a crucial role. These medications help speed up the movement of food from the stomach into the small intestine. Several different prokinetic drugs may be prescribed, sometimes in combination, depending on how well each one works for you. Alongside these, antiemetic agents help control nausea and vomiting, though they don’t directly improve stomach emptying.^[8][9]

For problems related to gastroesophageal reflux disease (GERD), several classes of medications provide relief. Antacids neutralize stomach acid immediately but work for a short time. H2 blockers, such as famotidine (Pepcid AC) and ranitidine (Zantac), reduce how much acid your stomach produces. Proton pump inhibitors like omeprazole (Prilosec), lansoprazole (Prevacid), and esomeprazole (Nexium) are even more powerful at reducing acid production and are often used for frequent heartburn.^[11]

Constipation related to motility disorders may be treated with secretagogues—medications that increase fluid secretion in the intestines to soften stool and promote movement. Cholinergic agonists are another class of drugs that stimulate the muscles of the digestive tract to contract more effectively.^[9]

Surgical and Procedural Treatments

When medications don’t provide adequate relief, several surgical and minimally invasive procedures are available. For achalasia, pneumatic dilation is a procedure where doctors insert a balloon into the lower esophagus and inflate it to stretch the tight muscle ring that prevents food from entering the stomach. This is typically done in stages, starting with a 30-millimeter balloon, then progressing to 35 millimeters and finally 40 millimeters if needed, with procedures spaced two to four weeks apart.^[9]

Another treatment for achalasia is peroral endoscopic myotomy (POEM), an innovative procedure performed entirely through the mouth without any abdominal incisions. During POEM, doctors use an endoscope—a thin, flexible tube with a camera—to cut the muscles around the opening to your stomach, making swallowing easier. This procedure can also be adapted for gastroparesis (G-POEM) by cutting the muscles between the stomach and small intestine, or for other swallowing problems (Z-POEM) by cutting muscles between the throat and esophagus.^[9][16]

For severe gastroparesis that doesn’t respond to medication, doctors may implant a gastric neurostimulator. This small, battery-powered device sits beneath the skin near your stomach and sends electrical pulses to the stomach nerves, helping reduce nausea and vomiting. In some severe cases, feeding tubes may be necessary to bypass the stomach and ensure proper nutrition and hydration.^[8][16]

Surgery for motility disorders is generally reserved for specific situations. For example, in cases of intractable constipation that doesn’t respond to medical therapy, or for intestinal pseudo-obstruction, surgical interventions may be considered. However, these surgeries are typically palliative, meaning they aim to relieve symptoms rather than cure the underlying problem.^[9]

Duration and Side Effects of Standard Therapy

The duration of treatment varies considerably depending on the condition. Some motility disorders require lifelong management with medications and lifestyle modifications, while others may improve with shorter courses of treatment. Your doctor will monitor your response to therapy and adjust your treatment plan as needed over time.^[10]

Side effects depend on the specific medications used. Prokinetic agents may cause headaches, diarrhea, or fatigue. Botulinum toxin injections typically have minimal side effects, though some people experience temporary difficulty swallowing or chest discomfort. Acid-reducing medications are generally well-tolerated, but long-term use of proton pump inhibitors has been associated with reduced absorption of certain vitamins and minerals, as well as a slightly increased risk of bone fractures and certain infections.^[11]

Dietary and Lifestyle Modifications

Diet plays a crucial role in managing motility disorders. For gastroparesis, eating smaller, more frequent meals rather than three large ones can help. Well-cooked fruits and vegetables, soft pasta, liquid-based diets, and ground or pureed meats are often easier to digest. Low-fat dairy products are typically recommended, as fat slows stomach emptying. Many people benefit from working with a dietitian who can create a personalized eating plan.^[11]

For constipation-related motility disorders, increasing dietary fiber gradually and staying well-hydrated helps soften stool and promote regular bowel movements. Conversely, people with diarrhea-predominant disorders may need to limit fiber and identify trigger foods that worsen their symptoms.^[10]

Cognitive and Behavioral Interventions

Cognitive behavioral therapy and hypnotherapy have shown success in managing abdominal pain in patients with irritable bowel syndrome, a common motility disorder. These approaches help people develop coping strategies for dealing with chronic symptoms and may reduce the perception of pain. However, they require significant time and effort from both patient and therapist, and access to trained practitioners may be limited.^[9][10]

Emerging Treatments in Clinical Trials

While standard treatments help many people with motility disorders, researchers continue to investigate new therapies that might work better or help people who haven’t found relief with existing options. Clinical trials test these innovative approaches in careful, controlled settings before they become widely available.

Understanding Clinical Trial Phases

Clinical trials progress through distinct phases, each designed to answer specific questions. Phase I trials focus on safety, determining if a new treatment is safe to use in humans and identifying any side effects. These studies typically involve small groups of people and help researchers understand how the body processes the medication.^[10]

Phase II trials examine whether the treatment actually works—does it improve symptoms or disease markers? These studies involve more participants and may be divided into substages. Phase IIa compares healthy people to those with the disease to establish benchmarks. Phase IIb tests whether the severity of disease affects how well the treatment works. Phase IIc evaluates how well the treatment predicts outcomes in people with suspected disease.^[10]

Phase III trials are large studies that compare the new treatment directly to the current standard treatment. Participants are randomly assigned to receive either the new therapy or the existing treatment, helping researchers determine if the new approach is better, worse, or equivalent to what’s currently available.^[10]

Phase IV trials continue after a treatment is approved and available to the public. These studies monitor long-term effectiveness and safety, often involving thousands of people over many years.^[10]

Promising Therapies Under Investigation

Research into motility disorders has expanded significantly in the past decade. Scientists now better understand the underlying causes of these conditions, including alterations in gut motility, intestinal barrier dysfunction, immune system problems in the gut, heightened sensitivity to normal digestive sensations, changes in gut secretions, bile acid malabsorption, and imbalances in the gut microbiome—the community of bacteria and other microorganisms living in your intestines.^[10]

Several innovative molecular and cellular approaches are being studied. These include therapies targeting specific pathways involved in nerve-muscle communication in the digestive tract, treatments that modify the gut microbiome to restore healthy bacterial balance, and approaches that address the gut-brain axis—the communication system between your digestive tract and your brain.^[10]

Some clinical trials are exploring fecal microbiota transplantation, a procedure where healthy gut bacteria from a donor are transferred to a patient to restore a balanced microbiome. Other studies investigate specific probiotics—beneficial bacteria—that might improve symptoms in people with functional gastrointestinal disorders.^[10]

Researchers are also testing new prokinetic medications with different mechanisms of action than existing drugs, hoping to find options that work better or have fewer side effects. Some of these drugs target specific receptors in the digestive tract that control muscle contractions and nerve signaling.^[10]

Advanced Diagnostic Technologies Supporting Treatment Development

The development of better treatments goes hand-in-hand with improvements in how we diagnose and understand motility disorders. Advanced diagnostic testing available at specialized centers helps researchers identify which patients might benefit most from specific treatments. These tests include high-resolution manometry, which measures pressure and muscle contractions with great precision, and wireless motility capsules that track movement through the entire digestive tract over several days.^[12]

Technologies like EndoFLIP, which uses a balloon-equipped catheter to measure how well muscles respond to stretching, provide detailed information about esophageal and stomach function. This helps researchers understand exactly what’s going wrong in each patient and design treatments that address the specific problem.^[4][12]

Participation in Clinical Trials

Clinical trials are conducted at major medical centers around the world, including locations in the United States, Europe, and other regions. Eligibility to participate depends on many factors, including the specific diagnosis, severity of symptoms, previous treatments tried, and overall health status. If you’re interested in participating in a clinical trial, discuss this with your gastroenterologist, who can help determine if any current trials might be appropriate for you.^[10]

The Challenge of Treatment Effectiveness

One of the fundamental challenges in treating motility disorders is that currently available therapies often lack long-term effectiveness and safety data. Many treatments provide symptom relief but don’t address the underlying mechanisms causing the disorder. This is why research continues to focus on developing pharmacological agents based on the cellular and molecular mechanisms that drive these conditions, as this approach may offer better long-term solutions.^[10]

The heterogeneous nature of motility disorders—meaning they have multiple causes and mechanisms—makes treatment development complex. What appears to be the same condition in two different patients may actually involve different underlying problems requiring different solutions. This is why personalized medicine approaches, where treatment is tailored to each individual’s specific situation, are becoming increasingly important.^[10]

Most Common Treatment Methods

• Medications
  • Calcium-channel blockers and nitrates to relax esophageal muscles in achalasia
  • Prokinetic agents to speed up movement of food through the stomach and intestines
  • Antiemetic agents to control nausea and vomiting
  • H2 blockers and proton pump inhibitors to reduce stomach acid production for GERD
  • Antacids to neutralize stomach acid
  • Foaming agents to prevent reflux
  • Secretagogues to increase intestinal fluid and promote bowel movements
  • Cholinergic agonists to stimulate digestive muscle contractions
  • Botulinum toxin injections to relax tight muscles in the esophagus or stomach
• Minimally Invasive Procedures
  • Pneumatic dilation using a balloon to stretch the lower esophageal sphincter
  • Peroral endoscopic myotomy (POEM) performed through the mouth to cut esophageal muscles
  • G-POEM for gastroparesis, cutting muscles between stomach and small intestine
  • Z-POEM for swallowing disorders affecting the throat
  • Gastric neurostimulator implantation to send electrical pulses to stomach nerves
  • Botox injections into the lower esophageal sphincter
• Dietary Modifications
  • Eating smaller, more frequent meals instead of three large meals
  • Consuming well-cooked fruits and vegetables, soft pasta, and pureed foods
  • Following liquid-based diets when needed
  • Choosing low-fat dairy products
  • Adjusting fiber intake based on symptoms (increasing for constipation, limiting for diarrhea)
  • Working with a dietitian to develop personalized eating plans
• Surgical Interventions
  • Endoscopic cecostomy for intractable constipation
  • Feeding tube placement to bypass stomach in severe gastroparesis
  • Surgical myotomy to cut abnormal esophageal muscles
  • Palliative surgery for intestinal pseudo-obstruction
• Cognitive and Behavioral Therapies
  • Cognitive behavioral therapy to manage chronic pain and develop coping strategies
  • Hypnotherapy for symptom management
  • Biofeedback techniques to improve control over digestive functions
• Experimental Approaches in Clinical Trials
  • Novel prokinetic medications targeting specific receptors
  • Fecal microbiota transplantation to restore gut bacterial balance
  • Probiotics for functional gastrointestinal disorders
  • Therapies targeting the gut-brain axis
  • Treatments addressing intestinal barrier dysfunction